bupropion and glp 1 Central peripheral mechanisms of appetite and satiety and site of Pharmacotherapy for Obesity: Recent Updates

The findings indicated that the absolute risk for suicide among broad groups of GLP-1 receptor agonist users are low and any potential risk increase would be small, the researchers wrote

However, there are several important considerations 3,4 : Safety and Efficacy Concerns: The FDA has received reports of adverse events related to compounded semaglutide

Side effects from a GLP-1 can range from mild to serious, which is why provider oversight is so important

However, given the safety or effectiveness concerns of anti-obesity drugs, many of the currently used drugs have limited clinical use

Because it contains bupropion HCI, CONTRAVE has a boxed warning to alert healthcare professionals and patients to the increased risk of suicidal thoughts and behaviors associated with antidepressant drugs

[DOI] [PMC free article] [PubMed] [Google Scholar] 125.Koopmann MC, Nelson DW, Murali SG, Liu X, Brownfield MS, Holst JJ, Ney DM